SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Indoco Remedies gets nod to manufacture Allopurinol tablets

29 Jul 2016 Evaluate

Indoco Remedies has received the approval from United States Food & Drug Administration (USFDA) to manufacture and market Allopurinol 100 mg & 300 mg tablets. Allopurinol is indicated for treatment of Gout. The market size of this product in the US is $169 million.

Indoco Remedies is engaged in the manufacturing and marketing of formulations (finished dosage forms) and active pharmaceutical ingredients (APIs) in India. Indoco, a $ 149 million Company, employs over 5500 people including 300 skilled scientists. The Company has 8 manufacturing facilities, 5 of which are for FDFs and 3 for APIs, supported by a state-of-the-art R&D Centre and a CRO facility.

Indoco Remedies Share Price

220.25 -7.95 (-3.48%)
11-May-2026 13:57 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1872.50
Dr. Reddys Lab 1294.15
Cipla 1321.15
Zydus Lifesciences 948.00
Lupin 2275.80
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×